Skip to content
Recall Observatory FDA recall evidence

Drug product

BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 2 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5378-56, UPC 3 0093-5378-56 5.

D-1324-2014

April 07, 2014

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 68069
Status
Terminated
Classification
Class II
Quantity
17,181 bottles
Official record key
drug-enforcement:D-1324-2014

Official wording

Reason: Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.

Code information: Lot #: 34013132A, 34013133A, 34013134A, 34013135A, 34013136A, Exp 11/14

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification